Industry

home-hero-underline

Thought leaders sharing decades of industry experience through publications and research

Latest News

DROX HEALTH SCIENCES JOINS THE ASSOCIATION OF DIVERSITY IN CLINICAL TRIALS AS A SUPPORTING PARTNER

ALLAS, May 23, 2023 /PRNewswire/ — The Association of Diversity in Clinical Trials (AOD), a diversity-focused organization whose mission is to set standards and best
Read More →

TOTAL DIVERSITY CLINICAL TRIAL MANAGEMENT EXPERIENCING RAPID GROWTH

DALLAS, April 13, 2023 /PRNewswire/ — TOTAL Diversity Clinical Trial Management (TOTAL), a full-service diversity organization announces the expansion of the business development and marketing teams to
Read More →

Announcing the Launch of The Association of Diversity in Clinical Trials

DALLAS, Feb. 3, 2023 /PRNewswire/ — The Association of Diversity in Clinical Trials (AOD) is being launched and introduced at upcoming industry conferences SCOPE and
Read More →

Introducing DTEACH©

Diversity and inclusion are key components of a culturally diverse workplace. It’s important for clinical research site personnel, clinical research associates, as well as project
Read More →

Total Diversity Clinical Trial Management Launches New Book, Diversity In Clinical Trials Best Practices and Perspectives for Industry and Clinical Research Sites

(PRNewsfoto/Total Diversity) DALLAS, Nov. 29, 2022 /PRNewswire/ — Total Diversity Clinical Trial Management (TOTAL), a global full-service Diversity Organization, has announced the launch of its
Read More →

ANZ Site Solutions Summit

After two years of virtual meetings due to the COVID-19 pandemic, it was with great pleasure to attend the in-person SCRS ANZ Site Solutions Summit
Read More →

Launching Meaningful Change in Diversity, Equity and Inclusion in Clinical Trials: Key Takeaways from the Diversity Site Solutions Summit (Part 2)

By Diana Foster, Ph.D., Vice President, Diversity, Equity, and Inclusion, Society for Clinical Research Sites The life sciences industry can, and should, be a driving
Read More →

Notable News from the SCRS Diversity Summit

Total Diversity and Parexel provided scholarships for patients and advocacy groups, as well as students and research sites to join the event at a discounted
Read More →

Launching Meaningful Change in Diversity, Equity, and Inclusion in Clinical Trials: Key Takeaways from the Diversity Site Solutions Summit ( Part 1 )

By Diana Foster, Ph.D., Vice President, Diversity, Equity, and Inclusion, Society for Clinical Research Sites Clinical research is a transformative avenue for addressing inequities in
Read More →

SCRS Puts A Spotlight On Diversity

June 9, 2022 – When asked about patient diversity in clinical trials, Diana Foster likes to reflect back to 2016. Foster, VP, strategy and special
Read More →

Society for Clinical Research Sites Organizes Successful Conference Discussing the Need for Diversity in Clinical Trials

May 22, 2022 – The drive to diversify clinical trials most definitely has intensified.  With a confluence of factors, from precision therapies needing investigational representation
Read More →

Industry Veteran Mark Hanley Joins Total Diversity Board of Directors

April 28, 2022 – Total Diversity Clinical Trial Management, a global Contract Research Organization and full-service Diversity Organization, has announced Mark Hanley as a Board Member
Read More →

The Society for Clinical Research Sites (SCRS) First in Kind Diversity Site Solutions Summit

April 13, 2022 – The Society of Clinical Research Sites (SCRS) will be hosting its inaugural Diversity Site Solutions Summit on 20 May 2022 in Austin, Texas.
Read More →

Total Diversity Clinical Trial Management Provides Signature Voice Sponsorship for First Site-Focused Diversity Conference in the Clinical Trials Industry

April 12, 2022 – Total Diversity Clinical Trial Management, a global Contract Research Organization and full-service Diversity Organization, is supporting the Society of Clinical Research Sites’
Read More →

Kenyetta Sims Announced as Director of Diversity Training & Education of Total Diversity Clinical Trial Management

March 15, 2022 – Total Diversity Clinical Trial Management, a global Contract Research Organization and full-service Diversity Organization, has announced Kenyetta Sims, MAOM, CCRC as
Read More →

Former Surgeon General Jerome Adams Announced as Chairman of the Board of Total Diversity Clinical Trial Management

March 8, 2022 – Total Diversity Clinical Trial Management, a global Contract Research Organization and full-service Diversity Organization, has announced former Vice Admiral Jerome Adams,
Read More →

Kim Kundert and Amanda Rangel Join Total Diversity Following the Announcement of Focused Diversity Services

September 30, 2021 – TOTAL Diversity (TOTAL), a woman-owned full service CRO with a long-standing history of recruiting and enrolling diverse populations, has appointed Kim
Read More →

Total Clinical Trial Management Announces the Launch of Total Diversity

September 28, 2021 – Total Clinical Trial Management (TCTM), a woman-owned full service CRO, has recently announced a new brand and new focus – TOTAL
Read More →

Conferences

Research Articles

Preparing Sites to Be Diverse Capable During Site Selection

With the recent passing of the Omnibus Spending Package, in 2023 the FDA will now make mandatory the filing of diversity plans to support Phase
Read More →

TOTAL Diversity’s Response to FDA’s Draft Guidance to Industry Regarding Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials

Total Diversity Clinical Trial Management (TOTAL, Dallas Texas) supports efforts to bring all aspects of Diversity into the management of clinical research trials and appreciates
Read More →

A Determination of Variables That Impact Research Site Best Practices: An Analysis of Clinical Trial Site Characteristics as Compared to Scores Using the SCRS Diversity Self-Assessment Tool (DSAT)

By Diana Foster, Ph.D., CEO, TOTAL Diversity Clinical Trial Management, Kim Kundert, RN/BSN, Sr. Vice President, Site Development Services, and Jerome Adams, M.D., Chairman of
Read More →

Consultative Opportunities

Dr. Diana Foster, Ph.D

An innovative leader

Diana Foster is a recognized expert in the intricacies of site management and an innovator in the use of strategic marketing and positioning tactics, her focus and strategic guidance in the area of diversity among clinical trials positions Diana as a continued thought leader related to this critical movement in the clinical trial industry.

Don't Let Site Enrollment Be
an Afterthought

Diana L. Foster, Ph.D

CEO and Chief Diversity Officer for TOTAL Diversity Clinical Trial Management

Diana L. Foster, Ph.D., is the CEO and Chief Diversity Officer for TOTAL Diversity Clinical Trial Management, a full-service Diversity Organization whose mission is to enhance diversity and inclusion in clinical research trials. Foster has served as the Vice President of Diversity, Equity, and Inclusion for the Society of Clinical Research Sites (SCRS) since 2016. She also held a position as the Vice President of Strategy and Development for SCRS originating programs such as the Global Impact Partner Programs and many other industry supported initiatives.

Foster is a thought-leader and sought-after expert in diversity and clinical site best practices. She is the author of the Diversity Site Assessment Tool and has published numerous research papers on the topic. Over the past two decades, she has addressed audiences across the world, published multiple papers and articles, and written five authoritative industry books including Global Issues in Patient Recruitment and Retention.

Jerome Adams, M.D.

Chairman of the Board for TOTAL Diversity Clinical Trial Management

Dr. Adams also currently serves as Executive Director of Health Equity Initiatives at Purdue University. He formerly served as the 20th United States Surgeon General and as a member of the President’s COVID-19 task force, where he was at the forefront of America’s most pressing health challenges throughout the pandemic, including working with companies to increase diversity in vaccine trials.

As the Chairman of the Board for TOTAL Diversity, Dr. Adams provides his in-depth knowledge of patient perspectives and industry views on diversity to create sustainable solutions and best practices to establish more diverse representation in clinical trials.